Editorial Comment to Prominent response to platinum-based chemotherapy in a patient with BRCA2 mutant-neuroendocrine prostate cancer and MDM2 amplification

Takashi Matsumoto; Masaki Shiota

doi:10.1002/iju5.12291

Editorial Comment to Prominent response to platinum-based chemotherapy in a patient with BRCA2 mutant-neuroendocrine prostate cancer and MDM2 amplification

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	219-220
Number of pages	2
Journal	IJU Case Reports
Volume	4
Issue number	4
DOIs	https://doi.org/10.1002/iju5.12291
Publication status	Published - Jul 2021

All Science Journal Classification (ASJC) codes

Urology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/iju5.12291

Cite this

@article{330458a2cbe64041b267ee48fcd37889,

title = "Editorial Comment to Prominent response to platinum-based chemotherapy in a patient with BRCA2 mutant-neuroendocrine prostate cancer and MDM2 amplification",

author = "Takashi Matsumoto and Masaki Shiota",

year = "2021",

month = jul,

doi = "10.1002/iju5.12291",

language = "English",

volume = "4",

pages = "219--220",

journal = "IJU Case Reports",

issn = "2577-171X",

publisher = "John Wiley and Sons Inc.",

number = "4",

}

TY - JOUR

T1 - Editorial Comment to Prominent response to platinum-based chemotherapy in a patient with BRCA2 mutant-neuroendocrine prostate cancer and MDM2 amplification

AU - Matsumoto, Takashi

AU - Shiota, Masaki

PY - 2021/7

Y1 - 2021/7

UR - http://www.scopus.com/inward/record.url?scp=85105017918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85105017918&partnerID=8YFLogxK

U2 - 10.1002/iju5.12291

DO - 10.1002/iju5.12291

M3 - Editorial

AN - SCOPUS:85105017918

SN - 2577-171X

VL - 4

SP - 219

EP - 220

JO - IJU Case Reports

JF - IJU Case Reports

IS - 4

ER -

Editorial Comment to Prominent response to platinum-based chemotherapy in a patient with BRCA2 mutant-neuroendocrine prostate cancer and MDM2 amplification

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this